Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

271

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Major Depressive Disorder
Interventions
DRUG

Pexacerfont

Tablets \& Capsules, Oral, 100 mg, Once daily, Up to 8 weeks followed by 8 weeks of observation

DRUG

Escitalopram

Tablets \& Capsules, Oral, 20 mg, Once daily, Up to 8 weeks followed by 8 weeks of observation.

DRUG

Placebo

Tablets \& Capsules, Oral, 0 mg, Once daily, Up to 8 weeks followed by 8 weeks of observation.

Trial Locations (45)

10016

Bioscience Research, Llc, New York

10021

Social Psychiatry Research Institute, New York

10305

Behavioral Medical Research Of Staten Island, Staten Island

11235

Social Psychiatry Research Institute, Brooklyn

11516

Neurobehavioral Research, Inc., Cedarhurst

19063

Suburban Research Associates, Media

20852

Dupont Clinical Research, Rockville

22905

Psychiatric Alliance Of The Blue Ridge, Charlottesville

23112

Dominion Clinical Research, Midlothian

27599

University Of North Carolina At Chapel Hill, Chapel Hill

27609

Richard H. Weisler, Md, Raleigh

29203

Usc School Of Medicine, Columbia

30329

Emory University, Atlanta

32216

Clinical Neuroscience Solutions, Inc., Jacksonville

32606

University Of Florida, Gainesville

32806

Clinical Neuroscience Solutions, Inc., Orlando

38119

Clinical Neuroscience Solutions, Inc., Memphis

45227

Community Research, Cincinnati

45408

Midwest Clinical Research Center, Dayton

47905

Alpine Clinic, Lafayette

48336

Summit Research Network, Farmington Hills

53223

Northbrooke Research Center, Brown Deer

53562

Dean Foundation For Health Research & Education, Middleton

55101

Regions Hospital, Saint Paul

60169

Alexian Center For Psychiatric Research, Hoffman Estates

60523

American Medical Research, Inc., Oak Brook

62025

Cunningham Clinical Research, Llc, Edwardsville

71104

J. Gary Booker, Md, Shreveport

72762

Apc Clinical Research Trials Nw, Pa, Springdale

75115

Insite Clinical Research, DeSoto

77401

Claghorn-Lesem Research Clinic, Bellaire

77566

R/D Clinical Research, Inc., Lake Jackson

78229

Croft, Harry A., San Antonio

78756

Futuresearch Trials, Austin

80033

Front Range Clinical Research, Wheat Ridge

84107

Radiant Research, Salt Lake City, Salt Lake City

84132

University Of Utah School Of Medicine, Salt Lake City

87102

Albuquerque Neuroscience, Inc., Albuquerque

91786

Pacific Clinical Research Medical Group, Upland

92868

Pacific Clinical Research Medical Group, Orange

97210

Oregon Center For Clinical Investigations, Inc. (Occi, Inc), Portland

Summit Research Network, Portland

98004

Northwest Clinical Research Center, Bellevue

98104

Summit Research Network (Seattle), Inc., Seattle

06030

University Of Connecticut Health Center, Farmington

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY